Previous Next

REFERENCES

451. Gribbin B, Pickering TG, Sleight P, Peto R: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 29:424–431, 1971.

452. Olshan AR, O'Connor DT, Cohen IM, et al: Baroreflex dysfunction in patients with adult-onset diabetes and hypertension. Am J Med 74:233–242, 1983.

453. Goldberg AH, Sohn YZ, Phear WP: Direct myocardial effects of nitrous oxide. Anesthesiology 37:373–380, 1972.

454. Price HL: Myocardial depression by nitrous oxide and its reversal by Ca++ . Anesthesiology 44:211–215, 1976.

455. Carton EG, Wanek LA, Housmans PR: Effects of nitrous oxide on contractility, relaxation and the intracellular calcium transient of isolated mammalian ventricular myocardium. J Pharmacol Exp Ther 257:843–849, 1991.

456. Craythorne NW, Darby TD: The cardiovascular effects of nitrous oxide in the dog. Br J Anaesth 37:560–565, 1965.

457. Smith NT, Eger EI II, Stoelting RK, et al: The cardiovascular and sympathomimetic responses to the addition of nitrous oxide to halothane in man. Anesthesiology 32:410–421, 1970.

458. Ebert TJ: Differential effects of nitrous oxide on baroreflex control of heart rate and peripheral sympathetic nerve activity in humans. Anesthesiology 72:16–22, 1990.

459. Ebert TJ, Kampine JP: Nitrous oxide augments sympathetic outflow: Direct evidence from human peroneal nerve recordings. Anesth Analg 69:444–449, 1989.

460. Sellgren J, Ponten J, Wallin BG: Percutaneous recording of muscle nerve sympathetic activity during propofol, nitrous oxide, and isoflurane anesthesia in humans. Anesthesiology 73:20–27, 1990.

461. Eisele JH, Smith NT: Cardiovascular effects of 40 percent nitrous oxide in man. Anesth Analg 51:956–963, 1972.

462. Eriksen S, Johannsen G, Frost N: Effects of nitrous oxide on systolic time intervals. Acta Anaesthesiol Scand 24:74–78, 1980.

463. Falk RB Jr, Denlinger JK, Nahrwold ML, Todd RA: Acute vasodilation following induction of anesthesia with intravenous diazepam and nitrous oxide. Anesthesiology 49:149–150, 1978.

464. Lichtenthal P, Philip J, Sloss LJ, et al: Administration of nitrous oxide in normal subjects. Evaluation of systems of gas delivery for their clinical use and hemodynamic effects. Chest 72:316–322, 1977.

465. Stoelting RK, Gibbs PS: Hemodynamic effects of morphine and morphine-nitrous oxide in valvular heart disease and coronary-artery disease. Anesthesiology 38:45–52, 1973.

466. Thornton JA, Fleming JS, Goldberg AD, Baird D: Cardiovascular effects of 50 percent nitrous oxide and 50 percent oxygen mixture. Anaesthesia 28:484–489, 1973.

467. Bahlman SH, Eger EI II, Smith NT, et al: The cardiovascular effects of nitrous oxide-halothane anesthesia in man. Anesthesiology 35:274–285, 1971.

468. Coetzee A, Fourie P, Bolliger C, et al: Effect of N2 O on segmental left ventricular function and effective arterial elastance in pigs when added to a halothane-fentanyl-pancuronium anesthetic technique. Anesth Analg 69:313–322, 1989.

469. Dolan WM, Stevens WC, Eger EI II, et al: The cardiovascular and respiratory effects of isoflurane-nitrous oxide anaesthesia. Can Anaesth Soc J 21:557–568, 1974.

470. Lappas DG, Buckley MJ, Laver MB, et al: Left ventricular performance and pulmonary circulation following addition of nitrous oxide to morphine during coronary-artery surgery. Anesthesiology 43:61–69, 1975.

471. Lunn JK, Stanley TH, Eisele J, et al: High dose fentanyl anesthesia for coronary artery surgery: Plasma fentanyl concentrations and influence of nitrous oxide on cardiovascular responses. Anesth Analg 58:390–395, 1979.

472. Smith NT, Calverley RK, Prys-Roberts C, et al: Impact of nitrous oxide on the circulation during enflurane anesthesia in man. Anesthesiology 48:345–349, 1978.

473. Van Trigt P, Christian CC, Fagraeus L, et al: Myocardial depression by anesthetic agents (halothane, enflurane and nitrous oxide): Quantitation based on end-systolic pressure-dimension relations. Am J Cardiol 53:243–247, 1984.

474. Pagel PS, Kampine JP, Schmeling WT, Warltier DC: Effects of nitrous oxide on myocardial contractility as evaluated by the preload recruitable stroke work relationship in chronically instrumented dogs. Anesthesiology 73:1148–1157, 1990.

475. Messina AG, Yao F-S, Canning H, et al: The effect of nitrous oxide on left ventricular pump performance and contractility in patients with coronary artery disease: Effect of preoperative ejection fraction. Anesth Analg 77:954–962, 1993.

476. Eisele JH, Reitan JA, Massumi RA, et al: Myocardial performance and N2 O analgesia in coronary-artery disease. Anesthesiology 44:16–20, 1976.

477. Hohner P, Backman C, Diamond G, et al: Anaesthesia for abdominal aortic surgery in patients with coronary artery disease. Part II. Effects of nitrous oxide on systemic and coronary haemodynamics, regional ventricular function and incidence of myocardial ischaemia. Acta Anaesthesiol Scand 38:793–804, 1994.

478. Houltz E, Caidahl K, Hellstrom A, et al: The effects of nitrous oxide on left ventricular systolic and diastolic performance before and after cardiopulmonary bypass: Evaluation by computer-assisted two-dimensional and Doppler echocardiography in patients undergoing coronary artery surgery. Anesth Analg 81:243–248, 1995.

479. Tempe D, Mohan JC, Cooper A, et al: Myocardial depressant effect of nitrous oxide after valve surgery. Eur J Anaesthesiol 11:353–358, 1994.


228


480. Marsch SCU, Dalmas S, Philbin DM, et al: Effects and interactions of nitrous oxide, myocardial ischemia, and reperfusion on left ventricular diastolic function. Anesth Analg 84:39–45, 1997.

481. Carton EG, Housmans PR: Role of transsarcolemmal Ca2+ entry in the negative inotropic effects of nitrous oxide in isolated ferret myocardium. Anesth Analg 74:575–579, 1992.

482. Su JY, Kerrick WGL, Hill SA: Effects of diethyl ether and nitrous oxide on functionally skinned myocardial cells of rabbits. Anesth Analg 63:451–456, 1984.

483. Kawamura R, Stanley TH, English JB, et al: Cardiovascular responses to nitrous oxide exposure for two hours in man. Anesth Analg 59:93–99, 1980.

484. Winter PM, Hornbein TF, Smith G, et al: Hyperbaric nitrous oxide anesthesia in man: Determination of anesthetic potency (MAC) and cardiorespiratory effects [abstract]. Proceedings of the American Society of Anesthesiologists Annual Meeting, 1972, Boston, pp 103–104.

485. Hornbein TF, Martin WE, Bonica JJ, et al: Nitrous oxide effects on the circulatory and ventilatory responses to halothane. Anesthesiology 31:250–260, 1969.

486. Moffitt EA, Sethna DH, Gary RJ, et al: Nitrous oxide added to halothane reduces coronary flow and myocardial oxygen consumption in patients with coronary disease. Can Anaesth Soc J 30:5–9, 1983.

487. McDermott RW, Stanley TH: The cardiovascular effects of low concentrations of nitrous oxide during morphine anesthesia. Anesthesiology 41:89–91, 1974.

488. Wong KC, Martin WE, Hornbein TF, et al: The cardiovascular effects of morphine sulfate with oxygen and with nitrous oxide in man. Anesthesiology 38:542–549, 1973.

489. Stoelting RK, Reis RR, Longnecker DE: Hemodynamic responses to nitrous oxide-halothane and halothane in patients with valvular heart disease. Anesthesiology 37:430–435, 1972.

490. Schulte-Sasse U, Hess W, Tarnow J: Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 57:9–13, 1982.

491. Rorie DK, Tyce GM, Sill JC: Increased norepinephrine release from dog pulmonary artery caused by nitrous oxide. Anesth Analg 65:560–564, 1986.

492. Hilgenberg JC, McCammon RL, Stoelting RK: Pulmonary and systemic vascular responses to nitrous oxide in patients with mitral stenosis and pulmonary hypertension. Anesth Analg 59:323–326, 1980.

493. Landry LD, Emerson CW, Philbin DM, et al: The effect of nitrous oxide on pulmonary vascular resistance in children. Anesth Analg 59:548–549, 1980.

494. Eisele Jr JH, Milstein JM, Goetzman BW: Pulmonary vascular responses to nitrous oxide in newborn lambs. Anesth Analg 65:62–64, 1986.

495. Davidson JR, Chinyanga HM: Cardiovascular collapse associated with nitrous oxide anaesthetic: A case report. Can Anaesth Soc J 29:484–488, 1982.

496. Roizen MF, Plummer GO, Lichtor JL: Nitrous oxide and dysrhythmias. Anesthesiology 66:427–431, 1987.

497. Liu WS, Wong KC, Port JD, Andriano KP: Epinephrine-induced arrhythmias during halothane anesthesia with the addition of nitrous oxide, nitrogen, or helium in dogs. Anesth Analg 61:414–417, 1982.

498. Eisele JH Jr: Cardiovascular effects of nitrous oxide. In Eger EI II (ed): Nitrous Oxide: N2 O. New York, Elsevier, 1985, pp 125–156.

499. Puerto BA, Wong KC, Puerto AX, et al: Epinephrine-induced dysrhythmias: Comparison during anaesthesia with narcotics and with halogenated inhalational agents in dogs. Can Anaesth Soc J 26:263–268, 1979.

500. Hughes JM, Sill JC, Pettis M, Rorie DK: Nitrous oxide constricts epicardial coronary arteries in pigs: Evidence suggesting inhibitory effects of endothelium. Anesth Analg 77:232–240, 1993.

501. Stowe DF, Monroe SM, Marijic J, et al: Effects of nitrous oxide on contractile function and metabolism of the isolated heart. Anesthesiology 73:1220–1226, 1990.

502. Dottori O, Haggendal E, Linder E, et al: The haemodynamic effects of nitrous oxide anaesthesia on myocardial blood flow in dogs. Acta Anaesthesiol Scand 20:421–428, 1976.

503. Wilkowski DAW, Sill JC, Bonta W, et al: Nitrous oxide constricts epicardial coronary arteries without effect on coronary arterioles. Anesthesiology 66:659–665, 1987.

504. Cason BA, Demas KA, Mazer CD, et al: Effects of nitrous oxide on coronary pressure and regional contractile function in experimental myocardial ischemia. Anesth Analg 72:604–611, 1991.

505. Nathan HJ: Nitrous oxide worsens myocardial ischemia in isoflurane-anesthetized dogs. Anesthesiology 68:407–415, 1988.

506. Philbin DM, Foex P, Drummond G, et al: Postsystolic shortening of canine left ventricle supplied by a stenotic coronary artery when nitrous oxide is added in the presence of narcotics. Anesthesiology 62:166–174, 1985.

507. Siker D, Pagel PS, Pelc LR, et al: Nitrous oxide impairs functional recovery of stunned myocardium in barbiturate-anesthetized, acutely instrumented dogs. Anesth Analg 75:539–548, 1992.

508. Nathan HJ: Control of hemodynamics prevents worsening of myocardial ischemia when nitrous oxide is administered to isoflurane-anesthetized dogs. Anesthesiology 71:686–694, 1989.

509. Kozmary SV, Lampe GH, Benefiel D, et al: No finding of increased myocardial ischemia during or after carotid endartarectomy under anesthesia with nitrous oxide. Anesth Analg 71:591–596, 1990.

510. Lawrence JH, Loomis WF, Tobias CA, Turpin FH: Preliminary observations on the narcotic effect of xenon with a review of values for solubilities of gases in water and oils. J Physiol (Lond) 105:197–204, 1946.

511. Steward A, Allott PR, Cowles AL, Mapleson WW: Solubility coefficients for inhaled anaesthetics in water, oil and biological media. Br J Anaesth 45:282–293, 1973.

512. Kennedy RR, Stokes JW, Downing P: Anaesthesia and the "inert" gases with special reference to xenon. Anaesth Intensive Care 20:66–70, 1992.

513. Luttropp HH, Romner B, Perhag L, Eskilsson J, Fredriken S, Werner O: Left ventricular performance and cerebral haemodynamics during xenon anaesthesia: A transesophageal echocardiography and transcranial Doppler sonography study. Anaesthesia 48:1045–1049, 1993.

514. Luttropp HH, Thomasson R, Dahm S, et al: Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol Scand 38:121–125, 1994.

515. Goto T, Saito H, Shinkai M, et al: Xenon provides faster emergence from anesthesia than does nitrous oxide-sevoflurane or nitrous oxide-isoflurane. Anesthesiology 86:1273–1278, 1997.

516. Yagi M, Mashimo T, Kawaguchi T, Yoshiya I: Analgesic and hypnotic effects of subanaesthetic concentrations of xenon in human volunteers: Comparison with nitrous oxide. Br J Anaesth 74:670–673, 1995.

517. Ohara A, Mashimo M, Zhang P, et al: A comparative study of the antinociceptive action of xenon and nitrous oxide. Anesth Analg 85:931–936, 1997.

518. Saito H, Saito M, Goto T, Morita S: Priming of anesthesia circuit with xenon for closed circuit anesthesia. Artif Organs 21:70–72, 1997.

519. Luttropp HH, Rydgren G, Thomasson R, Werner O: A minimal-flow system for xenon anesthesia. Anesthesiology 75:896–902, 1991.

520. Lynch C III, Baum J, Tenbrinck R: Xenon anesthesia. Anesthesiology 92:865–870, 2000.

521. Boomsma F, Rupreht J, Man in 't Veld AJ, et al: Haemodynamic and neurohumoral effects of xenon anaesthesia: A comparison with nitrous oxide. Anaesthesia 45:273–278, 1990.

522. Marx T, Froeba G, Wagner D, et al: Effects on haemodynamics and catecholamine release of xenon anaesthesia compared to total I.V. anaesthesia in the pig. Br J Anaesth 78:326–327, 1997.
229


523. Zhang P, Ohara A, Mashimo T, et al: Pulmonary resistance in dogs: A comparison of xenon with nitrous oxide. Can J Anaesth 42:547–553, 1995.

524. Preckel B, Ebel D, Mullenheim J, et al: The direct myocardial effects of xenon in the dog heart in vivo. Anesth Analg 94:545–551, 2002.

525. Nakata Y, Goto M, Saito H, et al: Plasma concentration of fentanyl with xenon to block somatic and hemodynamic responses to surgical incision. Anesthesiology 92:1043–1048, 2000.

526. Nakata Y, Goto T, Morita S: Effects of xenon on hemodynamic responses to skin incision in humans. Anesthesiology 90:406–410, 1999.

527. Stowe DF, Rehmert GC, Kwok WK, et al: Xenon does not alter cardiac function or major cation currents in isolated guinea pig hearts or myocytes. Anesthesiology 92:516–522, 2000.

528. Huneke R, Jugling E, Skasa M, et al: Effects of the anesthetic gases xenon, halothane, and isoflurane on calcium and potassium currents in human atrial cardiomyocytes. Anesthesiology 95:999–1006, 2001.

529. Preckel B, Mullenheim J, Moloschavij A, et al: Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 91:1327–1332, 2000.

530. Hettrick DA, Pagel PS, Kersten JR, et al: Cardiovascular effects of xenon in isoflurane-anesthetized dogs with dilated cardiomyopathy. Anesthesiology 1998; 89:1166–1173, 1998.

531. Ishiguro Y, Goto T, Nakata Y, et al: Effect of xenon on autonomic cardiovascular control—Comparison with isoflurane and nitrous oxide. J Clin Anesth 12:196–201, 2000.


230

Previous Next